Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia
Robak, Tadeusz, Trelinski, Jacek, von Depka Prondzinski, Mario, Giagounidis, Aristoteles, Doyen, Chantal, Janssens, Ann, Román, Mayte Álvarez, Pueyo, Javier Loscertales, Ramos, Isidro Jarque, Loscertales, Javier, Rus, Gloria Pérez, Hellmann, Andrzej, Wiktor-Jedrzejczak, Wieslaw, Kuliczkowski, Kazimierz, Golubovic, Lana, Celeketic, Dusica, Cucuianu, Andrei, Gheorghita, Emanuil, Mihaela, Lazaroiu, Attias, Dina, Shpilberg, Ofer, Karyagina, Elena, Vilchevska, Kateryna, Svetlana, Kalinina, Cooper, Nichola, Talks, Kate, Prabhu, Mukyaprana, Prasad, Sripada V.S.S, Bharadwaj, T.P. Raghava, Flensburg, Mimi Folden, Petersen, Jorgen, Windyga, Jerzy
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article